Výsledky vyhledávání

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: Results from the RELAX-AHF trial

Autor: Teerlink, John, Filippatos, G, Teerlink, JR, Farmakis, D, Cotter, G, Davison, BA, Felker, GM, Greenberg, BH, Hua, T, Ponikowski, P, Severin, T

Publikováno v: Teerlink, John; Filippatos, G; Teerlink, JR; Farmakis, D; Cotter, G; Davison, BA; et al.(2014). Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: Results from the RELAX-AHF trial. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/9k7624v0

Aims Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF). Many AHF patients have preserved ejection fraction (HFpEF). Given the lack of evidence-based therapies in this population, we evaluated th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::aa6cd1b88ade49bb4d57b9d5bbc77796
http://www.escholarship.org/uc/item/9k7624v0

Zobrazit plný text záznamu

Diuretic response in patients with acute decompensated heart failure: Characteristics and clinical outcome - An analysis from RELAX-AHF

Autor: Teerlink, John, Voors, AA, Davison, BA, Teerlink, JR, Felker, GM, Cotter, G, Filippatos, G, Greenberg, BH, Pang, PS, Levin, B, Hua, TA

Publikováno v: Teerlink, John; Voors, AA; Davison, BA; Teerlink, JR; Felker, GM; Cotter, G; et al.(2014). Diuretic response in patients with acute decompensated heart failure: Characteristics and clinical outcome-An analysis from RELAX-AHF. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/1kq832z2

© 2014 The Authors European Journal of Heart Failure.Aims We studied the characteristics and clinical outcome related to diuretic response and the effects of serelaxin in patients hospitalized for acute heart failure (AHF).Methods and results RELAX-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::63554a3822792cf64579caedcbc761d2
http://www.escholarship.org/uc/item/1kq832z2

Zobrazit plný text záznamu

Rational use of inotropic therapy in heart failure

Autor: O'Connor Cm, Felker Gm

Publikováno v: Current Cardiology Reports. 3:108-113

Despite their theoretic appeal, agents that increase cardiac contractility (positive inotropes) have consistently been shown to increase mortality when given chronically to patients with heart failure. The routine use of inotropes as heart failure th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eebc99a80877bc76e12f5601355117be
https://doi.org/10.1007/s11886-001-0035-8

Zobrazit plný text záznamu

Effects of serelaxin in subgroups of patients with acute heart failure: Results from RELAX-AHF

Autor: Teerlink, John, Metra, M, Ponikowski, P, Cotter, G, Davison, BA, Felker, GM, Filippatos, G, Greenberg, BH, Hua, TA, Severin, T, Unemori, E

Publikováno v: Teerlink, John; Metra, M; Ponikowski, P; Cotter, G; Davison, BA; Felker, GM; et al.(2013). Effects of serelaxin in subgroups of patients with acute heart failure: Results from RELAX-AHF. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/54v4c0wk

Aim Patients hospitalized for acute heart failure (AHF) differ with respect of many clinical characteristics which may influence their prognosis and response to treatment.We have assessed possible differences in the effects of serelaxin on dyspnoea r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::1f5ab24fd2b908a0b666548feadf46c6
http://www.escholarship.org/uc/item/54v4c0wk

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání